Metastasis: recent discoveries and novel treatment strategies

SA Eccles, DR Welch - The Lancet, 2007 - thelancet.com
Most cancer deaths are due to the development of metastases, hence the most important
improvements in morbidity and mortality will result from prevention (or elimination) of such …

Molecular interactions in cancer cell metastasis

SA Brooks, HJ Lomax-Browne, TM Carter, CE Kinch… - Acta histochemica, 2010 - Elsevier
Metastasis, the process by which cancer cells leave the primary tumour, disseminate and
form secondary tumours at anatomically distant sites, is a serious clinical problem as it is …

[HTML][HTML] Anti-PlGF inhibits growth of VEGF (R)-inhibitor-resistant tumors without affecting healthy vessels

C Fischer, B Jonckx, M Mazzone, S Zacchigna… - Cell, 2007 - cell.com
Novel antiangiogenic strategies with complementary mechanisms are needed to maximize
efficacy and minimize resistance to current angiogenesis inhibitors. We explored the …

Therapeutic application of anti-angiogenic nanomaterials in cancers

S Mukherjee, CR Patra - Nanoscale, 2016 - pubs.rsc.org
Angiogenesis, the formation of new blood vessels from pre-existing vasculature, plays a vital
role in physiological and pathological processes (embryonic development, wound healing …

Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates

S Loges, T Schmidt, P Carmeliet - Genes & cancer, 2010 - journals.sagepub.com
The concept of inhibiting tumor neovessels has taken the hurdle from the bench to the
bedside and now represents an extra pillar of anticancer treatment. So far, anti-angiogenic …

[HTML][HTML] Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways

A Klettner, J Roider - Investigative ophthalmology & visual …, 2008 - tvst.arvojournals.org
purpose. Vascular endothelial growth factor (VEGF) antagonists are the therapy of choice for
age-related macular degeneration. Ranibizumab and pegaptanib have been approved by …

Oral complications of targeted cancer therapies: a narrative literature review

AL Watters, JB Epstein, M Agulnik - Oral oncology, 2011 - Elsevier
The aim of the present study was to investigate the available literature regarding the oral
side effects or adverse events associated with targeted cancer therapy. Common oral …

[HTML][HTML] Role of bevacizumab in colorectal cancer growth and its adverse effects: a review

ET Pavlidis, TE Pavlidis - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Angiogenesis affects both wound healing and malignant cell growth through nutrients and
oxygen. Vascular endothelial growth factor (VEGF) is the most important element involved in …

Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation

R Hlushchuk, O Riesterer, O Baum, J Wood… - The American journal of …, 2008 - Elsevier
Inhibitors of angiogenesis and radiation induce compensatory changes in the tumor
vasculature both during and after treatment cessation. To assess the responses to irradiation …

Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer

BM Künzli, MI Bernlochner, S Rath, S Käser… - Purinergic …, 2011 - Springer
Despite improvements in prevention and management of colorectal cancer (CRC),
uncontrolled tumor growth with metastatic spread to distant organs remains an important …